Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

European shares dip on heavy earnings day as euro rebounds

Published 05/03/2018, 04:59 AM
Updated 05/03/2018, 04:59 AM
© Reuters. 20 Euro banknotes are displayed is this picture illustration

© Reuters. 20 Euro banknotes are displayed is this picture illustration

By Danilo Masoni

MILAN (Reuters) - European bourses fell in morning trading on Thursday, weighed down by a rebound in the euro and a series of disappointing earning updates including from Smith & Nephew.

The pan-European STOXX 600 index (STOXX) fell 0.2 percent, retracing from three-month highs, while Germany's DAX (GDAXI) and Britain's FTSE also fell slightly.

The euro rose off four-month lows as the dollar's recent rally came to a halt after the U.S. Federal Reserve did little to alter market expectations for further interest rate rises this year.

"European markets were on the back foot in early trade as investors digest the aftermath of the Fed’s no-surprise rate hold and US-China trade talks weigh," said Neil Wilson, Chief Market Analyst at Markets.com.

"The Fed left rates on hold as expected and signaled that it’s unlikely to respond too aggressively if we get some hot summer inflation readings this year," he added.

In earnings, Smith & Nephew (L:SN) slumped 6.8 percent after Europe's biggest artificial hip and knee maker cut its forecast for full-year underlying revenue growth after some markets softened and it saw a slowdown in its bioactives business.

"Following on from weak results from competitors, results across most product lines were slightly soft... However, Bioactives was the major disappointment," said UBS in a note.

Bpost (BR:BPOST) fell 12 percent, leading fallers on the STOXX, and Schibsted (OL:SBSTA) declined 5.5 as results lagged expectations.

Adidas (DE:ADSGn) fell as much as 3.5 percent after the German sportswear firm posted sales growth slightly shy of analyst expectations, although net profit rose more than expected. The stock recovered some of its losses and was down 1 percent.

Results elsewhere showed the negative impact of strength in the euro during the first quarter.

German drug and crop chemical Bayer (DE:BAYGn) cut its full-year guidance as a stronger euro weighs on the value of overseas revenues. Its shares edged up 0.1 percent.

Adverse currency also led to a 2 percent revenue drop at healthcare group Fresenius (DE:FREG) and resulted in a lower-than-expected core profit for Belgian chemicals group Solvay (BR:SOLB).

Fresenius fell 1 percent and Solvay was down 2.2 percent.

Elsewhere, however, some well-received company updates provided support. Logitech (S:LOGN) rose 9.1 percent following a better than expected quarterly results.

French utility Veolia (PA:VIE) rose 2.5 percent after quarterly revenues rose, as its French water business returned to growth and international activities also showed double-digit growth.

© Reuters. 20 Euro banknotes are displayed is this picture illustration

Overall, first quarter earnings for the euro zone MSCI index are seen up 2.5 percent in euro terms or 14.6 percent in dollar terms, according to Thomson Reuters data.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.